Personalized medicine: Where do we go from here?

The past decade has seen a surplus of nanotechnology-based methodologies for “theranostic” application, sensors, and real-time monitoring of biological events, therapy, and image-guided precision drug delivery. While nanotechnology offers great promise to address some of the critical clinical challenges, the future of this technology toward personalized medicine will largely be predisposed by design principles for developing translatable, “safer” nanoplatforms in concert with imaging agents, therapy, and homing ligands.